CClinicalTrials.gg
Not yet recruitingNCT07705646RIRS-VENTUpdated Jul 15, 2026

Comparison of Different Ventilation Modes for Reducing Kidney Motion During Retrograde Intrarenal Surgery

An interventional study of Standard Ventilation and Hypoventilation in Kidney Stones and Nephrolithiasis, sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-07-15.

Sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This randomized clinical trial will compare four ventilation strategies during retrograde intrarenal surgery performed under general anesthesia. The study aims to determine whether reducing respiratory-related kidney movement improves surgical success and decreases perioperative complications. Eighty adult patients will be randomly assigned to standard ventilation, hypoventilation, intermittent apnea ventilation, or one-lung ventilation. Surgical outcomes and perioperative complications will be compared between groups.

Read the detailed description

Retrograde intrarenal surgery is commonly performed under general anesthesia, but respiratory movement may interfere with kidney stability during the procedure. This prospective, randomized, single-center trial will compare standard ventilation, hypoventilation, intermittent apnea ventilation, and one-lung ventilation in adult patients undergoing retrograde intrarenal surgery. The primary objective is to determine whether different ventilation strategies improve surgical success by reducing kidney movement. Secondary outcomes include operative time, stone access time, fluoroscopy time, laser use time, complications, length of hospital stay, and postoperative stone-free rate.

02

Conditions studied

  • Kidney Stones
  • Nephrolithiasis

Keywords

  • Retrograde Intrarenal Surgery
  • RIRS
  • Mechanical Ventilatio
  • General Anesthesia
  • Kidney Motion
03

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Age 18-75 years. ASA physical status I-III. Scheduled for elective RIRS/RIRC under general anesthesia. No obstructive or restrictive pulmonary disease. No history of pneumothorax. No pulmonary mass or other significant respiratory disease. Normal coagulation parameters and not receiving antithrombotic therapy. No active urinary tract infection. Written informed consent.

Exclusion criteria

Exclusion Criteria:

Age \<18 or >75 years. ASA IV. Obstructive or restrictive pulmonary disease. History of pneumothorax. Pulmonary mass or significant respiratory disease. Receiving antithrombotic therapy or abnormal coagulation. Active urinary tract infection or urinary tract anatomical abnormality. Refusal or inability to provide informed consent.

04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    Standard Ventilation

    Patients will receive standard volume-controlled mechanical ventilation during retrograde intrarenal surgery under general anesthesia.

    Procedure: Standard Ventilation

  • Experimental
    Hypoventilation

    Patients will receive hypoventilation with reduced tidal volume and respiratory rate during retrograde intrarenal surgery under general anesthesia.

    Procedure: Hypoventilation

  • Experimental
    Intermittent Apnea Ventilation

    Patients will receive intermittent apnea periods during selected surgical steps, in coordination with the surgeon.

    Procedure: Intermittent Apnea Ventilation

  • Experimental
    One-Lung Ventilation

    Patients will receive one-lung ventilation during selected surgical steps, in coordination with the surgeon.

    Procedure: One-Lung Ventilation

Interventions

  • ProcedureStandard Ventilation

    Volume-controlled mechanical ventilation using standard ventilator settings during general anesthesia.

  • ProcedureHypoventilation

    Volume-controlled mechanical ventilation using reduced tidal volume and respiratory rate during general anesthesia.

  • ProcedureIntermittent Apnea Ventilation

    Intermittent apnea periods applied during selected stages of retrograde intrarenal surgery to reduce kidney motion.

  • ProcedureOne-Lung Ventilation

    One-lung ventilation applied during selected stages of retrograde intrarenal surgery to reduce kidney motion.

05

What researchers measure

Primary outcomes

  1. Kidney Motion During Retrograde Intrarenal Surgery

    Kidney motion during surgery will be evaluated and compared among the four ventilation strategies.

    Time frame: During surgery

Secondary outcomes

  1. Stone-free Rate

    Percentage of patients who are stone-free after retrograde intrarenal surgery.

    Time frame: Postoperative Day 30

  2. Operative Time

    Total duration of surgery measured from the beginning to the end of the surgical procedure.

    Time frame: During surgery

  3. Fluoroscopy Time

    Total fluoroscopy exposure time recorded during the procedure.

    Time frame: During surgery

  4. Laser Activation Time

    Total duration of laser use during stone fragmentation.

    Time frame: During surgery

  5. Perioperative Complications

    Occurrence of intraoperative and postoperative complications.

    Time frame: Periprocedural

  6. Length of Hospital Stay

    Number of days of hospitalization.

    Time frame: Periprocedural

06

Study locations

1 site
  • Sultan Abdulhamid Han Training and Research Hospital
    Istanbul, Istanbul 34668, Turkey (Türkiye)
    • Tuna Ertürk, MD · Contact · tunaerturk22@yahoo.com · +905325010066
    • Hakan Emirkadı, MD · Contact · hemirkadi@gmail.com · 05322609367
    • Tuna Ertürk, MD · Principal investigator
    • Hakan Emirkadı, MD · Sub investigator
07

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made publicly available to protect participant confidentiality.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07705646
Lead sponsor
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Responsible party
Tuna Erturk (Principal Investigator, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey) — Principal investigator
First posted
Jul 15, 2026
Start date
Jul 15, 2026 (estimated)
Primary completion
Nov 15, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Jul 15, 2026

Study contacts

Tuna Ertürk, MD
Contact
tunaerturk22@yahoo.com
+905325010066
Hakan Emirkadı, MD
Contact
suheylaatay81@gmail.com
+905322609367
Tuna Ertürk, MD
principal investigator · University of Health Sciences Sultan 2. Abdulhamid Han Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion